LONDON, Aug. 6, 2020 /PRNewswire/ -- Davidson Kempner notes Thermo Fisher Scientific's statement dated 4 August 2020 and reiterates its position that it considers the current offer wholly inadequate and will not be tendering its shares.
For media enquiries:
Andrew Honnor, Rob White, Fanni Bodri
Tel: +44 (0) 20 7952-2000
SOURCE Davidson Kempner